Guided Therapeutics (GTHP) Convertible Debt (2014 - 2026)
Guided Therapeutics (GTHP) posted Convertible Debt of $35000.0 for Q1 2025, up 150.0% sequentially from $14000.0 in Q4 2024, and down 96.9% YoY from $1.1 million in Q1 2024.
Guided Therapeutics (GTHP) Convertible Debt (2014 - 2026) Analysis & Trends
Guided Therapeutics has reported Convertible Debt for 12 years, with the latest figure at $35000.0 in Q1 2025.
- Quarterly Convertible Debt fell 96.9% year-over-year to $35000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $35000.0 (down 96.9% YoY) and the FY2024 annual result came in at $14000.0, changed N/A from the prior year.
- Convertible Debt climbed to $35000.0 in Q1 2025 per GTHP's latest filing, from $14000.0 in the prior quarter.
- Over five years, Convertible Debt peaked at $1.1 million in Q1 2024 and troughed at $14000.0 in Q4 2024.
- A 5-year average of $612750.0 and a median of $803000.0 in 2021 frame the typical range for Convertible Debt.
- The sharpest annual moves came in 2021 and 2025: Convertible Debt jumped 978.43% in 2021, then plunged 96.9% in 2025.
- Over 5 years, Convertible Debt stood at $820000.0 in 2021, then increased by 27.56% to $1.0 million in 2022, then retreated by 6.12% to $982000.0 in 2023, then tumbled by 98.57% to $14000.0 in 2024, then soared by 150.0% to $35000.0 in 2025.
- According to Business Quant data, Convertible Debt over the past three periods registered $35000.0, $14000.0, and $162000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20,000.00 |
| Dec 31, 2025 | 20.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2023 | 982,000.00 |
| Dec 31, 2022 | 1.05 Mn |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 786,000.00 |
| Mar 31, 2022 | 161,000.00 |
| Dec 31, 2021 | 820,000.00 |
| Mar 31, 2021 | 1.10 Mn |
| Dec 31, 2020 | 161,000.00 |
| Sep 30, 2020 | 622,000.00 |
| Jun 30, 2020 | 525,000.00 |
| Mar 31, 2020 | 102,000.00 |
| Dec 31, 2019 | 512.72 Mn |
| Sep 30, 2019 | 65,000.00 |